Nakhaipour HR - Search Results

1

A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies.

Duquette P, Yeung M, Mouallif S, Nakhaipour HR, Haddad P, Schecter R. Duquette P, et al. Among authors: nakhaipour hr. PLoS One. 2019 Jan 14;14(1):e0210417. doi: 10.1371/journal.pone.0210417. eCollection 2019. PLoS One. 2019. PMID: 30640935 Free PMC article.

2

The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis.

Freedman MS, Duquette P, Grand'Maison F, Lee L, Vorobeychik G, Lara N, Khurana V, Nakhaipour HR, Schecter R, Haddad P. Freedman MS, et al. Among authors: nakhaipour hr. Curr Med Res Opin. 2019 May;35(5):767-776. doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21. Curr Med Res Opin. 2019. PMID: 30614288

3

Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada.

Nakhaipour HR, Vudumula U, Khurana V, Sébire G, Mah JK, Pohl D, Schecter R, Adlard N. Nakhaipour HR, et al. J Med Econ. 2020 Dec;23(12):1525-1533. doi: 10.1080/13696998.2020.1840138. Epub 2020 Nov 12. J Med Econ. 2020. PMID: 33079578 Free article.

4

Diagnosis and management of secondary-progressive multiple sclerosis: time for change.

Oh J, Alikhani K, Bruno T, Devonshire V, Giacomini PS, Giuliani F, Nakhaipour HR, Schecter R, Larochelle C. Oh J, et al. Among authors: nakhaipour hr. Neurodegener Dis Manag. 2019 Dec;9(6):301-317. doi: 10.2217/nmt-2019-0024. Epub 2019 Nov 26. Neurodegener Dis Manag. 2019. PMID: 31769344 Free article. Review.

5

Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension.

Nakhai-Pour HR, Rey E, Bérard A. Nakhai-Pour HR, et al. Am J Obstet Gynecol. 2009 Aug;201(2):180.e1-8. doi: 10.1016/j.ajog.2009.05.019. Am J Obstet Gynecol. 2009. PMID: 19646568

6

Use of antidepressants during pregnancy and the risk of spontaneous abortion.

Nakhai-Pour HR, Broy P, Bérard A. Nakhai-Pour HR, et al. CMAJ. 2010 Jul 13;182(10):1031-7. doi: 10.1503/cmaj.091208. Epub 2010 May 31. CMAJ. 2010. PMID: 20513781 Free PMC article.

7

Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.

Herring W, Pearson I, Purser M, Nakhaipour HR, Haiderali A, Wolowacz S, Jayasundara K. Herring W, et al. Among authors: nakhaipour hr. Pharmacoeconomics. 2016 Jan;34(1):77-90. doi: 10.1007/s40273-015-0332-5. Pharmacoeconomics. 2016. PMID: 26518293

8

Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States.

Delea TE, Amdahl J, Diaz J, Nakhaipour HR, Hackshaw MD. Delea TE, et al. Among authors: nakhaipour hr. J Manag Care Spec Pharm. 2015 Jan;21(1):46-54, 54a-b. doi: 10.18553/jmcp.2015.21.1.46. J Manag Care Spec Pharm. 2015. PMID: 25562772 Free PMC article.

9

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada.

Amdahl J, Diaz J, Park J, Nakhaipour HR, Delea TE. Amdahl J, et al. Among authors: nakhaipour hr. Curr Oncol. 2016 Aug;23(4):e340-54. doi: 10.3747/co.23.2244. Epub 2016 Aug 12. Curr Oncol. 2016. PMID: 27536183 Free PMC article.

10

Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders.

Bérard A, Azoulay L, Nakhai-Pour HR, Moussally K. Bérard A, et al. Dermatology. 2011;223(1):45-51. doi: 10.1159/000330326. Epub 2011 Aug 25. Dermatology. 2011. PMID: 21865673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page